The Clinical Impact of JAK2V617F allele burden in Philadelphia-negative myeloproliferative neoplasms
<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a research archivist expert in dataset metadata. Answer the question truthfully.  <|eot_id|><|start_header_id|>user<|end_header_id|> Here is the Description of a dataset. Description:'We analyzed the clinical impact of JAK2V617F allele burden in a relatively large patient series of Philadelphia-negative (Ph-negative) myeloproliferative neoplasms (MPNs) with long term follow-up' . Please return only a json list of at most 3 Keywords corresponding to the Description:.<|eot_id|><|start_header_id|>assistant<|end_header_id|> {"Answer" : ["Hematology"]} <|eot_id|>
 Here is the Description of a dataset. Description:'We analyzed the clinical impact of JAK2V617F allele burden in a relatively large patient series of Philadelphia-negative (Ph-negative) myeloproliferative neoplasms (MPNs) with long term follow-up' . Please return only a json list of at most 3 Keywords corresponding to the Description:.
We analyzed the clinical impact of JAK2V617F allele burden in a relatively large patient series of Philadelphia-negative (Ph-negative) myeloproliferative neoplasms (MPNs) with long term follow-up
Hematology